Cellerix

company

About

Cellerix is a biotechnology company developing therapies based on adult stem cells.

  • 51 - 100

Details

Last Funding Type
Series B
Last Funding Money Raised
€27M
Industries
Biotechnology,Medical,Pharmaceutical
Founded date
Jan 1, 2004
Number Of Employee
51 - 100
Operating Status
Active

Cellerix, S.A., a biotechnology company, engages in the development and production of medicines based on the use of stem cells of adult origin. The company offers products for the treatment of gastroenterology, dermatology, and immune-based diseases. Its products include Cx401, which is used for the treatment of complex perianal fistulas; and Cx501, a cell therapy product to be applied in the treatment of Epidermolysis Bullosa. Cellerix, S.A. was founded in 2004 and is based in Tres Cantos, Spain.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€27M
Cellerix has raised a total of €27M in funding over 2 rounds. Their latest funding was raised on Nov 11, 2009 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 11, 2009 Series B €27M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Cellerix is funded by 1 investors. Biopartners Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Biopartners Capital Series B